Furostanol saponins from Asparagus racemosus as potential hypoglycemic agents

Phytochemistry. 2022 Sep:201:113286. doi: 10.1016/j.phytochem.2022.113286. Epub 2022 Jun 23.

Abstract

Bioactivity guided phytochemical investigation led to isolation of six undescribed furostanol saponins, furoasparoside A-F along with five known compounds, gallic acid, methyl gallate, quercetin-3-O-β-glucopyranoside, liquiritigenin 4׳-O-β-apiofuranosyl-(1 → 2)-β-glucopyranoside and β-glucogallin for the first time from the roots of Asparagus racemosus. Isolated saponins were screened for their antidiabetic potential in L6-GLUT4myc myotubes in vitro followed by an in vivo evaluation in streptozocin-induced diabetic rats and db/db mice. Furoasparoside E produced a notable decrease in the postprandial blood glucose profile, in leptin receptor-deficient db/db mice, type 2 diabetes model. The effect of furoasparoside E on GLUT4 translocation was found to be mediated by the AMPK-dependent signaling pathway in L6-GLUT4myc myotubes. Moreover, it emerged as a stable plant metabolite with higher bioavailability and efficacy in in vivo pharmacokinetic studies. Therefore, these studies indicated that furoasparoside E may serve as a propitious lead for the management of type 2 diabetes and its secondary complications from natural source.

Keywords: AMPK signaling Pathway; Antihyperglycaemic; Asparagaceae; Asparagus racemosus; Furostanol saponin; GLUT4 translocation; Type 2 diabetes mellitus (T2DM).

MeSH terms

  • Animals
  • Asparagus Plant* / chemistry
  • Asparagus Plant* / metabolism
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Experimental* / drug therapy
  • Diabetes Mellitus, Experimental* / metabolism
  • Diabetes Mellitus, Type 2* / drug therapy
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Mice
  • Rats
  • Saponins* / chemistry
  • Saponins* / pharmacology

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Saponins